Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Heparin Anticoagulation for Prevention of Death in Patients With Septic Shock.

NCT01234285 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01234285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01234285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Heparin Anticoagulation for Prevention of Death in Patients With Septic Shock.
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2010
Completion date
October 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis